rhodioloside has been researched along with Non-alcoholic Fatty Liver Disease in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Dun, Y; Li, D; Li, H; Liu, J; Liu, S; Qiu, L; Ripley-Gonzalez, JW; You, B; Zhang, J | 1 |
| Liang, Y; Liu, X; Lu, L; Qu, B; Zhang, C; Zheng, K | 1 |
| Hu, Y; Li, H; Tian, H; Xi, Y; Xin, X | 1 |
| Hu, M; Huang, X; Qi, Z; Shi, H; Wang, X; Wu, Y; Xu, H; Zhang, D; Zhang, Y | 1 |
| Bian, F; Chen, L; Jin, S; Li, W; Wang, Q; Wu, D; Xing, S; Yang, X; Zheng, T | 1 |
| Li, HS | 1 |
| Dai, N; Guan, LL; Wang, HF; Yang, ZR; Zuo, TC | 1 |
1 review(s) available for rhodioloside and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Salidroside in the Treatment of NAFLD/NASH.
Topics: Fibrosis; Glucosides; Humans; Liver; Liver Cirrhosis; Non-alcoholic Fatty Liver Disease | 2022 |
6 other study(ies) available for rhodioloside and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Rhodiola activates macrophage migration inhibitory factor to alleviate non-alcoholic fatty liver disease.
Topics: Animals; Blood Glucose; Diet, High-Fat; Glucosides; Insulin; Lipid Metabolism; Liver; Macrophage Migration-Inhibitory Factors; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Palmitates; Phenols; Plant Extracts; Rhodiola; RNA, Small Interfering; Saline Solution; Triglycerides | 2022 |
Salidroside improves high-fat diet-induced non-alcoholic steatohepatitis by regulating the gut microbiota-bile acid-farnesoid X receptor axis.
Topics: Animals; Bile Acids and Salts; Diet, High-Fat; Disease Models, Animal; Gastrointestinal Microbiome; Glucosides; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Phenols; Receptors, Cytoplasmic and Nuclear; Triglycerides | 2020 |
Salidroside Activates the AMP-Activated Protein Kinase Pathway to Suppress Nonalcoholic Steatohepatitis in Mice.
Topics: AMP-Activated Protein Kinases; Animals; Cells, Cultured; Diet, High-Fat; Disease Models, Animal; Glucosides; Hepatocytes; Humans; Liver; Male; Mice; Non-alcoholic Fatty Liver Disease; Phenols; Primary Cell Culture; Signal Transduction | 2021 |
Salidroside Attenuates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease via AMPK-Dependent TXNIP/NLRP3 Pathway.
Topics: Animals; Diet, High-Fat; Glucosides; Male; Mice; Non-alcoholic Fatty Liver Disease; Phenols; Rhodiola | 2018 |
Salidroside and Curcumin Formula Prevents Liver Injury in Nonalcoholic Fatty Liver Disease in Rats.
Topics: AMP-Activated Protein Kinases; Animals; Biomarkers; Blood Glucose; Curcumin; Diet, High-Fat; Disease Models, Animal; Drug Combinations; Glucosides; Insulin; Insulin Resistance; Lipid Metabolism; Lipid Peroxidation; Liver; Male; Non-alcoholic Fatty Liver Disease; Phenols; Rats, Sprague-Dawley; Signal Transduction | 2018 |
Salidroside alleviates oxidative stress in the liver with non- alcoholic steatohepatitis in rats.
Topics: Administration, Oral; Animals; Antioxidants; Cytochrome P-450 CYP2E1; Diet, High-Fat; Dose-Response Relationship, Drug; Enzyme Repression; Glucosides; Lipid Droplets; Lipid Metabolism; Lipid Peroxidation; Liver; Male; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidases; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Oxidoreductases; Phenols; Random Allocation; Rats, Sprague-Dawley; Up-Regulation | 2016 |